SEK275.00
2.07% today
Stockholm, Apr 04, 05:29 pm CET
ISIN
SE0000872095
Symbol
SOBI
Sector
Industry

Swedish Orphan Biovitrum Target price 2025 - Analyst rating & recommendation

Swedish Orphan Biovitrum Classifications & Recommendation:

Buy
71%
Hold
21%
Sell
7%

Swedish Orphan Biovitrum Price Target

Target Price SEK366.58
Price SEK275.00
Potential
Number of Estimates 12
12 Analysts have issued a price target Swedish Orphan Biovitrum 2026 . The average Swedish Orphan Biovitrum target price is SEK366.58. This is higher than the current stock price. The highest price target is
SEK400.00 45.45%
register free of charge
, the lowest is .
A rating was issued by 14 analysts: 10 Analysts recommend Swedish Orphan Biovitrum to buy, 3 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Swedish Orphan Biovitrum stock has an average upside potential 2026 of . Most analysts recommend the Swedish Orphan Biovitrum stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion SEK 26.03 28.62
17.64% 9.96%
EBITDA Margin 36.65% 37.25%
3.61% 1.65%
Net Margin 14.92% 16.97%
28.70% 13.71%

12 Analysts have issued a sales forecast Swedish Orphan Biovitrum 2025 . The average Swedish Orphan Biovitrum sales estimate is

SEK28.6b
Unlock
. This is
9.95% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
SEK30.1b 15.50%
Unlock
, the lowest is
SEK26.6b 2.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 SEK26.0b 17.64%
2025
SEK28.6b 9.96%
Unlock
2026
SEK32.2b 12.62%
Unlock
2027
SEK36.5b 13.27%
Unlock
2028
SEK38.2b 4.72%
Unlock
2029
SEK38.3b 0.30%
Unlock

11 Analysts have issued an Swedish Orphan Biovitrum EBITDA forecast 2025. The average Swedish Orphan Biovitrum EBITDA estimate is

SEK10.7b
Unlock
. This is
12.09% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
SEK11.7b 22.90%
Unlock
, the lowest is
SEK9.9b 4.09%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 SEK9.5b 21.89%
2025
SEK10.7b 11.77%
Unlock
2026
SEK12.5b 17.63%
Unlock
2027
SEK14.6b 16.54%
Unlock
2028
SEK14.4b 1.77%
Unlock
2029
SEK15.4b 7.62%
Unlock

EBITDA Margin

2024 36.65% 3.61%
2025
37.25% 1.65%
Unlock
2026
38.91% 4.46%
Unlock
2027
40.03% 2.88%
Unlock
2028
37.55% 6.20%
Unlock
2029
40.29% 7.30%
Unlock

13 Swedish Orphan Biovitrum Analysts have issued a net profit forecast 2025. The average Swedish Orphan Biovitrum net profit estimate is

SEK4.9b
Unlock
. This is
24.56% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK5.7b 47.49%
Unlock
, the lowest is
SEK3.9b 0.97%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 SEK3.9b 51.41%
2025
SEK4.9b 25.00%
Unlock
2026
SEK6.6b 36.36%
Unlock
2027
SEK8.7b 30.91%
Unlock
2028
SEK8.9b 2.82%
Unlock
2029
SEK9.6b 7.94%
Unlock

Net Margin

2024 14.92% 28.70%
2025
16.97% 13.71%
Unlock
2026
20.54% 21.04%
Unlock
2027
23.74% 15.58%
Unlock
2028
23.31% 1.81%
Unlock
2029
25.09% 7.64%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share SEK 11.31 14.14
51.41% 25.02%
P/E 19.86
EV/Sales 3.92

13 Analysts have issued a Swedish Orphan Biovitrum forecast for earnings per share. The average Swedish Orphan Biovitrum EPS is

SEK14.14
Unlock
. This is
24.58% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
SEK16.74 47.49%
Unlock
, the lowest is
SEK11.24 0.97%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 SEK11.31 51.41%
2025
SEK14.14 25.02%
Unlock
2026
SEK19.28 36.35%
Unlock
2027
SEK25.24 30.91%
Unlock
2028
SEK25.95 2.81%
Unlock
2029
SEK28.01 7.94%
Unlock

P/E ratio

Current 24.74 17.37%
2025
19.86 19.73%
Unlock
2026
14.57 26.64%
Unlock
2027
11.13 23.61%
Unlock
2028
10.82 2.79%
Unlock
2029
10.02 7.39%
Unlock

Based on analysts' sales estimates for 2025, the Swedish Orphan Biovitrum stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.30 13.83%
2025
3.92 8.95%
Unlock
2026
3.48 11.20%
Unlock
2027
3.07 11.72%
Unlock
2028
2.93 4.51%
Unlock
2029
2.92 0.30%
Unlock

P/S ratio

Current 3.71 9.67%
2025
3.37 9.05%
Unlock
2026
2.99 11.20%
Unlock
2027
2.64 11.72%
Unlock
2028
2.52 4.51%
Unlock
2029
2.51 0.30%
Unlock

Current Swedish Orphan Biovitrum Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HSBC
Locked
Locked
Locked Nov 24 2024
BERENBERG
Locked
Locked
Locked Oct 30 2024
PARETO SECURITIES AS
Locked
Locked
Locked Oct 27 2024
DNB MARKETS
Locked
Locked
Locked Oct 24 2024
Analyst Rating Date
Locked
HSBC:
Locked
Locked
Nov 24 2024
Locked
BERENBERG:
Locked
Locked
Oct 30 2024
Locked
PARETO SECURITIES AS:
Locked
Locked
Oct 27 2024
Locked
DNB MARKETS:
Locked
Locked
Oct 24 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today